#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	6042	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2659	450.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1831	1831	T	616	T,C,G	399,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	6042	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2659	450.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1565	1565	C	764	C,A,G	492,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11086	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3885	556.0	0	.	n	.	0	T695C	SNP	695	695	T	1265	1265	C	832	C,A	528,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11086	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3885	556.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1907	1907	A	568	A,C	387,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11086	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3885	556.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2208	2208	G	585	G	411	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11086	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3885	556.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2541	2541	C	608	C,A	402,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11086	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3885	556.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2615	2615	A	635	A	419	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11086	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3885	556.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3167	3167	C	787	C,A	512,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	11086	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3885	556.0	0	HET	.	.	.	C2525T	.	2525	2525	C	3095	3095	C	796	C,T	405,118	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	386	folP	855	855	100.0	folP.l6.c4.ctg.1	1698	46.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1079	1081	AGC	65;65;64	A;G;C	48;47;47	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1026	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3375	60.0	1	SNP	p	S91F	1	.	.	271	273	TTC	497	499	TTC	66;66;66	T;T;C	41;43;43	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1026	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3375	60.0	1	SNP	p	G95N	0	.	.	283	285	GGC	509	511	GGC	74;76;76	G;G;C	50;51;51	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1026	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3375	60.0	1	SNP	p	D95G	1	.	.	283	285	GGC	509	511	GGC	74;76;76	G;G;C	50;51;51	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	426	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1470	59.3	1	SNP	p	G45D	0	.	.	133	135	GGC	500	502	GGC	119;119;119	G;G;C	80;80;79	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	286	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1005	55.8	0	.	n	.	0	A197.	DEL	197	197	A	556	556	A	117	A	78	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1038	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3133	66.6	1	SNP	p	D86N	0	.	.	256	258	GAC	604	606	GAC	100;100;104	G;A;C	66;55;69	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1038	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3133	66.6	1	SNP	p	R87I	0	.	.	259	261	CGT	607	609	CGT	104;104;105	C;G;T	75;67;71	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1038	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3133	66.6	1	SNP	p	S87R	1	.	.	259	261	CGT	607	609	CGT	104;104;105	C;G;T	75;67;71	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1038	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3133	66.6	1	SNP	p	R87W	0	.	.	259	261	CGT	607	609	CGT	104;104;105	C;G;T	75;67;71	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1038	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3133	66.6	1	SNP	p	S88P	0	.	.	262	264	TCC	610	612	TCC	105;105;105	T;C;C,A	73;71;74,2	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	874	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2398	70.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1484	1486	GGC	62;63;61	G;G;C	42;44;42	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1275	1277	GCA	122;123;124	G;C;A	84;84;83	penA.41.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1278	1280	ATC	130;128;128	A;T;C	88;90;89	penA.41.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1290	1292	GTG	127;127;127	G;T,C;G	88;84,2;86	penA.41.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1290	1292	GTG	127;127;127	G;T,C;G	88;84,2;86	penA.41.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1794	1796	ACC	85;85;83	A;C;C	57;61;61	penA.41.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1848	1850	GCG	68;68;68	G;C;G	49;47;48	penA.41.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1848	1850	GCG	68;68;68	G;C;G	49;47;48	penA.41.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1971	1973	AGC	85;88;89	A,C;G;C	60,1;64;64	penA.41.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1980	1982	GGC	80;80;79	G;G;C,G	56;55;54,1	penA.41.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	1192	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2291	98.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1998	2000	CCG	77;75;75	C,G;C,A,G;G,C	52,1;51,1,1;49,2	penA.41.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1906	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3430	105.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1750	1752	CCG	81;81;81	C;C;G	59;60;55	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	516	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2098	48.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	668	668	C	47	C	29	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	671	673	GAA	120;113;115	G,T;A;A	86,1;83;84	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	920	922	AAC	88;88;87	A;A,C;C,A,G	68;67,1;66,1,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	959	961	GAT	74;80;80	G,A;A;T	57,1;62;59	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1082	1084	TCA	140;135;135	T,G;C;A	97,1;95;96	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1211	1213	ATC	152;158;163	A;T,G;C,T	97;101,1;102,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1331	1333	CAT	117;106;106	C;A,C;T	79;72,1;73	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1442	1444	GGT	122;121;117	G;G;T	84;83;80	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1541	1543	GCA	102;102;101	G;C;A	75;75;74	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	774	porB1b	1047	1047	98.95	porB1b.l6.c4.ctg.1	2221	68.1	1	SNP	p	G120K	1	.	.	358	360	AAG	917	919	AAG	90;90;88	A;A;G	69;69;69	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	40	porB3	990	116	92.24	porB3.l15.c4.ctg.1	353	16.7	0	.	p	.	0	M18T	NONSYN	52	54	ATG	246	248	ACG	23;23;23	A;C;G	14;14;14	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	40	porB3	990	116	92.24	porB3.l15.c4.ctg.1	353	16.7	0	.	p	.	0	T29A	NONSYN	85	87	ACC	279	281	GCC	22;22;18	G;C;C	15;15;11	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	40	porB3	990	116	92.24	porB3.l15.c4.ctg.1	353	16.7	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	288	290	CAA	16;16;16	C;A;A	9;9;9	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	40	porB3	990	116	92.24	porB3.l15.c4.ctg.1	353	16.7	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	294	296	TAC	8;8;8	T;A;C	5;5;5	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2948	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4841	119.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	256	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1106	50.1	1	SNP	p	V57M	1	.	.	169	171	ATG	619	621	ATG	96;95;95	A;T,G;G,T	68;66,1;66,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
